ORDER ARTESUNATE – USA

A time-critical drug for treating severe malaria

American Flag

ARTESUNATE

AMIVAS (US), LLC

A TIME CRITICAL DRUG FOR TREATING SEVERE MALARIA

EMERGENCY ORDERING OF ARTESUNATE

OPEN 24/7/365

Note: Please use the emergency ordering numbers below (do not use your regular ordering phone numbers)
*In the event you are unable to procure product urgently, please obtain product from any other distributor

AMERISOURCEBERGEN ASD HEALTHCARE

1-800-746-6273

CARDINAL HEALTH SPECIALITY PHARMACEUTICAL DISTRIBUTION

1-866-677-4844

MCKESSON PLASMA & BIOLOGICS

1-877-625-2566

AMERISOURCEBERGEN FULL LINE HEALTHCARE

1-844-222-2273 (NOT 24/7)

FFF ENTERPRISES

1-800-843-7477

FOR NON-EMERGENCY ORDERING:

CARDINAL HEALTH – 3PL Services – via email GMB-SPS-Amivas@cordlogistics.com

FFF ENTERPRISES -Distribution and Consignment – via email AcuteCareClientManagers@fffenterprises.com

AMIVAS MEDICAL AFFAIRS – OPEN 24/7/365 1-855-5AMIVAS

*Healthcare professionals with product related questions including difficulties obtaining product emergently from our distributors should contact the Amivas Medical Affairs immediately

Note: Please leave a voice message with your contact number for a PATIENT EMERGENCY. All voice messages will be called back within 30 minutes.

EMERGENCY MEDICAL ADVICE:

 Healthcare professionals who would like a consultation regarding how to treat a patient who has severe malaria can contact the CDC at (770) 488-7788 Mon – Fri, 9am–5pm EST. After hours, call (770) 488-7100

**The CDC has discontinued distribution of unregistered Intravenous Artesunate.

CDC has provided advice on the timely treatment of malaria at the following link:

http://www.cdc.gov/malaria

Download a PDF of the ordering instructions

Download Artesunate – USA Ordering Instructions.

Download a PDF of the ordering instructions

Download Artesunate – USA Ordering Instructions.

Return of Goods Policy

Download our Return of Goods Policy (PDF).

Registering Artesunate use during pregnancy

Please register treatments of pregnant women by enrolling in our study.

  • Call 1-855-526-4827 (1-855-5AMIVAS)
  • Press option 2 on IVR.

The treatment will be registered with AMIVAS’ Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and their Infants Registry.